copywriting
Marketing copy for homepages, landing pages, pricing pages, and other conversion-focused web pages.
clinical-trial-investigator-agreement
Drafts U.S. clinical trial Investigator Agreements between sponsors/CROs and principal investigators or institutions for FDA-regulated drug, biologic, or device studies. Enforces 21 CFR Parts 50, 56, 312/812, ICH GCP E6(R2), HIPAA, IRB requirements, FMV/AKS payment compliance, data integrity, publication rights, IP ownership, indemnity, and audit access. Use when drafting investigator agreements, PI agreements, clinical trial site agreements, or sponsor-PI contracts; trigger keywords: investigator agreement, clinical trial agreement, PI agreement, FDA, IND, IDE, IRB, GCP, clinical research agreement, site agreement.
Full skill instructions
Drafts a sponsor–PI/site agreement that operationalizes FDA, IRB, and GCP obligations for a specific clinical trial.
| Topic | Authority |
|---|---|
| Informed consent | 21 CFR Part 50; LAR, assent where required |
| IRB | 21 CFR Part 56; 45 CFR 46 when institution requires |
| Drugs/Biologics | 21 CFR Part 312; IND obligations flow down |
| Devices | 21 CFR Part 812; IDE obligations flow down |
| GCP | ICH GCP E6(R2) |
| Financial disclosure | 21 CFR Part 54 |
| Privacy | HIPAA and state privacy laws |
| Vulnerable populations | 45 CFR 46 Subparts B, C, D |
| Section | Must Include |
|---|---|
| Parties and Definitions | Sponsor, institution, PI; define Study, Protocol, Investigational Product, SAE, Confidential Information |
| Study Description | Protocol incorporated by reference; scope; single vs multi-center |
| Investigator Responsibilities | Conduct per protocol; no deviations except to eliminate immediate hazard; amendment approval workflow |
| IRB and Approvals | No study activities before written IRB approval; continuing review; submissions shared with sponsor |
| Informed Consent | Current IRB-approved forms; qualified designee; no coercion; LAR and assent as applicable |
| Study Personnel | Delegation of authority log; training documentation; PI retains ultimate responsibility |
| Investigational Product | Receipt only from sponsor; storage conditions; accountability logs; no off-protocol use; return/destroy per sponsor |
| Safety Reporting | AE/SAE definitions; sponsor reporting timelines; IRB reporting for unanticipated problems |
| Data Integrity | ALCOA+; source data verification; correction rules; EDC audit trail |
| Records and Retention | Essential documents per ICH GCP § 8; retention per 21 CFR 312.62(c) / 812.140(d), or longer per law/policy |
| Monitoring and Access | Reasonable advance notice; direct source access; HIPAA minimum necessary; corrective actions |
| Regulatory Inspections | Notify sponsor within 24 hours; provide FDA 483 or correspondence within 5 business days |
| Confidentiality | Scope; permitted disclosures to IRB/regulators; term and return/destruction |
| Data and IP Ownership | Sponsor owns study data and results; invention assignment; sample ownership with institutional carve-outs |
| Publications | Sponsor review window; patent delay; multicenter coordination; ICMJE authorship standards |
| Compensation and Budget | FMV/AKS compliance; invoicing; screen fail and early withdrawal rules; startup/closeout costs |
| Financial Disclosure/COI | 21 CFR Part 54 disclosures; update obligations; conflict management |
| Indemnification | Sponsor product liability indemnity; carve-outs for PI/site negligence or noncompliance |
| Insurance | Sponsor clinical trial liability; site professional liability; certificate requirements |
| Term and Termination | For cause and convenience; subject safety wind-down; payment of earned fees |
| Governing Law/Disputes | State law selection; venue or negotiation/mediation steps |
| Compliance | FCPA/UK Bribery Act; export control/OFAC; Sunshine Act reporting |
Adjust to protocol/IRB policy.
| Event | Default |
|---|---|
| Sponsor notification of SAE | Within 24 hours of awareness |
| IRB submission of unanticipated problems | Per IRB policy, prompt reporting |
| Publication review by sponsor | 45–60 days before submission |
| Patent delay after review | Up to 60–90 days |
[VERIFY]| Issue | Resolution |
|---|---|
| Unclear whether drug or device track applies | Confirm IND (21 CFR 312) vs IDE (21 CFR 812) with sponsor; combination products follow primary mode of action |
| Institution requires its own template | Merge sponsor terms into institutional template; flag conflicts for negotiation |
| Public entity cannot indemnify | Carve out sovereign immunity; shift to insurance-only model with higher certificate minimums |
| PI holds multiple roles (e.g., also sponsor-investigator) | Apply 21 CFR 312.50–312.70 sponsor obligations in addition to investigator duties |
| Budget exceeds FMV benchmarks | Document FMV analysis methodology; adjust per AAMC/PhRMA guidelines to avoid AKS risk |
[VERIFY].Marketing copy for homepages, landing pages, pricing pages, and other conversion-focused web pages.
Fast image generation with Flux 2 Klein, optimized for sub-second iteration and multi-reference brand styling.
Psychological principles and mental models for understanding customer behavior and influencing marketing decisions.
Plan searchable and shareable content that drives traffic, builds authority, and generates leads.
Build SEO-optimized pages at scale using templates, data, and proven playbook patterns.
Brainstorm and prioritize marketing strategies tailored to your SaaS stage, budget, and goals.
Optimize content for discovery, citation, and visibility across AI search platforms and LLM assistants.
Systematic improvement of existing marketing copy through seven focused editing passes.
Plan and optimize your website's page hierarchy, navigation, URL structure, and internal linking.
Design and optimize systems connecting marketing, sales, and customer success into a unified revenue engine.
Applies Anthropic's official brand colors and typography to any sort of artifact that may benefit from having Anthropic's look-and-feel. Use it when brand colors or style guidelines, visual formatting, or company design standards apply.
Convert websites into professional HyperFrames videos with guided storyboarding and brand-aligned composition.
Revolutionize Video Creation with AI-Generated Avatars and Voices
Social media on autopilot
Design custom logos instantly with AI.
Text-heavy marketing and design images
Boost Your SEO with Content and SEO Silos
Revolutionize Your Marketing with AI-Powered MarketingBlocks!
10X faster & free AI content creation for 100+ use cases
Tribescaler | Make Your Tweets Go Viral